Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cresco Labs Inc CRLBF


Primary Symbol: C.CL

Cresco Labs Inc. is an integrated multi-state cannabis operator in the United States. The Company is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs’ national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy’s.... see more

CSE:CL - Post Discussion

Cresco Labs Inc > Amazon endorses federal cannabis legislation
View:
Post by kijiji on Feb 07, 2022 7:45pm

Amazon endorses federal cannabis legislation

Amazon endorses federal cannabis legislation from Republican Congresswoman Nancy Mace.

Amazon.com on Tuesday said the company supports a measure by Congresswoman Nancy Mace, D.-S.C., to legalize cannabis. "We're pleased to endorse @RepNancyMace's States Reform Act," the company said. "Like so many in this country, we believe it's time to reform the nation's cannabis policy and Amazon is committed to helping lead the effort." The measure, which was formally introduced in November, would decriminalize cannabis from Schedule I with states to decide on prohibition or regulation. It would also regulate cannabis on a federal level similar to alcohol, and introduce a 3% federal excise tax on cannabis to pay for law enforcement, small business and veterans' health. It would also allow medical research of cannabis.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities